EJP PHARMACEUTICAL ApS: Financial statements 2024
CVR: 87923614
EJP PHARMACEUTICAL ApS (CVR 87923614) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -32,946 and a net result of DKK 414,071 compared with DKK 453,582 the year before. Equity amounted to DKK 4,428,783. The solvency ratio was 98.1%. The company had 1 employee in the financial year.
- Gross Profit
- -32,946 kr.
- Profit/Loss
- 414,071 kr.
- Equity
- 4,428,783 kr.
- Total Assets
- 4,513,036 kr.
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -33 t. | 414 t. | 4.4 mio. | 1 |
| 2023 | - | -34 t. | 454 t. | 4.1 mio. | 1 |
| 2022 | - | -49 t. | -478 t. | 6.7 mio. | 1 |
| 2021 | - | -40 t. | 443 t. | 7.3 mio. | 1 |
| 2020 | - | -75 t. | -140 t. | 6.9 mio. | 1 |
How creditworthy is EJP PHARMACEUTICAL ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2024
EJP PHARMACEUTICAL ApS has published its annual report for 2023. Gross profit came to DKK -34,271, and the net result was DKK 453,582.
About EJP PHARMACEUTICAL ApS
EJP PHARMACEUTICAL ApS is a Danish company of the type Anpartsselskab based in Skodsborg, founded in 1982. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Ejvind Jersie Pedersen. The company is owned by Ejvind Jersie Pedersen. The company has 1 employee. In 2025, the company reported a gross profit of DKK -28,266 and a net result of DKK 214,282 compared with DKK 414,071 the year before. Equity amounted to DKK 814,282.
